Core Viewpoint - WeDoctor, a well-known AI healthcare solution provider, is seeking to go public in Hong Kong, having submitted its prospectus to the Hong Kong Stock Exchange at the end of last year [1] Financial Performance - WeDoctor's revenue from 2021 to 2023 was 962 million, 1.368 billion, and 1.863 billion respectively, with revenue for the first half of 2024 reaching 1.818 billion, representing a year-on-year growth of 107.4% [3] - The adjusted loss rate decreased from 140.8% in 2021 to 27.1% in 2023, further dropping to 7.0% in the first half of 2024, indicating a significant reduction in losses and nearing profitability [3] Regulatory Challenges - WeDoctor's path to listing has faced setbacks, including a request for supplementary materials from the International Department of the China Securities Regulatory Commission (CSRC) in April 2025, focusing on the historical violations of its actual controller, Liao Jieyuan [4] - In July 2022, the CSRC imposed a fine of 30.3 million on WeDoctor for failing to timely disclose changes in its holdings of Yilianzhong shares and for misleading statements, with Liao Jieyuan fined 80,000 [5] - The Shenzhen Stock Exchange publicly reprimanded WeDoctor and Liao Jieyuan on January 17, 2024 [6] Management and Operations - The current CEO of WeDoctor is Zhang Jun, born in 1987, who previously held senior positions at Meitu and NetEase [6] - WeDoctor's digital healthcare platform connects approximately 11,500 medical institutions and 318,000 doctors, with its AI medical services showing effectiveness in regions like Tianjin [8]